bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients
with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.
NASDAQ: BlUE (common stock)Refresh Quote
|Data provided by Nasdaq. Minimum 15 minutes delayed.|